The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer

被引:25
|
作者
Chen, Sufeng [1 ]
Zhang, Jie [1 ]
Li, Xuebing [2 ]
Luo, Xiaoyang [1 ]
Fang, Jing [2 ]
Chen, Haiquan [1 ]
机构
[1] Fudan Univ, Canc Hosp, Inst Canc, Dept Thorac Surg, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
Apoptosis; Bax; Bcl-2; Non-small cell lung cancer; Prolyl hydroxylases; HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; HIF; PROTEIN; APOPTOSIS; FAMILY; ACTIVATION; PHYSIOLOGY; ALPHA; PHD3;
D O I
10.1007/s11010-011-0976-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prolyl hydroxylase domain enzymes (PHDs) play the most notable role in cellular oxygen sensing and oxygen homeostasis, the transcription of PHD genes are involved in the protection against hypoxia and oxidative stress. Intratumoral hypoxia exists in malignant solid tumors primarily due to rapid cancer cell proliferation with high metabolic demands and defective structural and functional vasculature. Previous studies have demonstrated that all the three PHDs have the ability to hydroxylate hypoxia inducible factor (HIF) polypeptides, which are the key molecules in maintaining the oxygen homeostasis. However, PHDs play multiple physiological and pathological roles. There is scant data regarding expression of PHDs genes in non-small cell lung cancer (NSCLC) tissues. In Addition, the relationship between PHDs and apoptosis has never been explored in NSCLC. In this article, we examined the expression of PHD genes and their relationship with the tumor behavior and apoptosis-associated factors in NSCLC. Our results indicated that the expression of PHDs was much higher in lung cancer tissue than that of adjacent normal tissue, and the high expression of PHD3 was associated with early tumor stage and well differentiation in NSCLC. Moreover, increased PHD3 expression was significantly correlated with the low expression of Bcl-2, suggesting its potential role in inducing apoptosis.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 50 条
  • [41] Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines
    Loprevite, M
    Varesco, L
    Favoni, R
    Ferrara, GB
    Moro, F
    Ottaggio, L
    Fronza, G
    Campomenosi, P
    Abbondandolo, A
    Cutrona, G
    Roncella, S
    Albini, A
    Aluigi, MG
    Pozzi, S
    Pera, C
    Biticchi, R
    Gismondi, V
    Grossi, F
    Pennucci, MC
    Ardizzoni, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (06) : 1203 - 1208
  • [42] BCL-2, BCL-XL, AND PP32/PHAPI IN RESECTED NON-SMALL CELL LUNG CANCER PATIENTS
    Schmidt, Lars Henning
    Kuemmel, Andreas
    Martin, Schuler M.
    Biesterfeld, Stefan
    Faldum, Andreas
    Sebastian, Martin
    Taube, Christian
    Buhl, Roland
    Wiewrodt, Rainer
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3479 - 3479
  • [43] Bcl-2 expression in non-small cell lung cancers: Higher frequency of expression in squamous cell carcinomas with earlier pT status
    Dosaka-Akita, H
    Katabami, M
    Hommura, H
    Fujioka, Y
    Katoh, H
    Kawakami, Y
    ONCOLOGY, 1999, 56 (03) : 259 - 264
  • [44] Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small cell lung cancer
    Borner, MM
    Brousset, P
    Pfanner-Meyer, B
    Bacchi, M
    Vonlanthen, S
    Hotz, MA
    Altermatt, HJ
    Schlaifer, D
    Reed, JC
    Betticher, DC
    BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) : 952 - 958
  • [45] Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer
    Lai, RS
    Wang, JS
    Hsu, HK
    Chang, HC
    Lin, CH
    Lin, MH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (10) : 393 - 397
  • [46] Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases
    Anton, RC
    Brown, RW
    Younes, M
    Gondo, MM
    Stephenson, MA
    Cagle, PT
    HUMAN PATHOLOGY, 1997, 28 (09) : 1079 - 1082
  • [47] Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer
    Nakano, J
    Huang, CL
    Liu, DG
    Ueno, M
    Sumitomo, S
    Yokomise, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (05) : 1215 - 1221
  • [48] ARVCF expression is significantly correlated with the malignant phenotype of non-small cell lung cancer
    Zhang, Di
    Tang, Na
    Liu, Yang
    Wang, En-Hua
    MOLECULAR CARCINOGENESIS, 2015, 54 : E185 - E191
  • [49] miR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7
    Xiang, Jie
    Hang, Jun-Biao
    Che, Jia-Ming
    Li, He-Cheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9147 - 9153
  • [50] Plasma thioredoxin reductase activity, a diagnostic biomarker, is up-regulated in resectable non-small cell lung cancers
    Zhou, Ming
    Ma, Weiwei
    Zhang, Yongchang
    Wang, Wenxiang
    Xiao, Gaoming
    Ye, Suofu
    Chen, Xue
    Zeng, Huihui
    Yang, Nong
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (02) : 383 - +